about
Gangliosides in breast cancer: new perspectivesRole of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and CancerCarbohydrate-to-carbohydrate interactions between α2,3-linked sialic acids on α2 integrin subunits and asialo-GM1 underlie the bone metastatic behaviour of LNCAP-derivative C4-2B prostate cancer cellsGlycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages.TNF up-regulates ST3GAL4 and sialyl-Lewisx expression in lung epithelial cells through an intronic ATF2-responsive element.TNF induces the expression of the sialyltransferase ST3Gal IV in human bronchial mucosa via MSK1/2 protein kinases and increases FliD/sialyl-Lewis(x)-mediated adhesion of Pseudomonas aeruginosa.Glycosylation Changes Triggered by the Differentiation of Monocytic THP-1 Cell Line into Macrophages.B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract.Gangliosides: Structures, Biosynthesis, Analysis, and Roles in Cancer.TNF regulates sialyl-Lewisx and 6-sulfo-sialyl-Lewisx expression in human lung through up-regulation of ST3GAL4 transcript isoform BX.TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.Gangliosides in Cancer Cell Signaling.Hyperacidification of trans-Golgi network and endo/lysosomes in melanocytes by glucosylceramide-dependent V-ATPase activity.The extended cytoplasmic tail of the human B4GALNT2 is critical for its Golgi targeting and post-Golgi sortingIdentification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2) as main O-acetylated sialic acid species of GD2 in breast cancer cellsGangliosides: The Double-Edge Sword of Neuro-Ectodermal Derived TumorsProfiling of O-acetylated Gangliosides Expressed in Neuroectoderm Derived Cells
P50
Q26779036-3BF7409A-F765-4695-B4B6-EA16523162B6Q28077907-E3363221-B107-4F40-90D3-E1248304AB36Q34197482-C49B55F6-8447-4FD1-BF4F-391D6858D4D6Q34257399-03A8507C-904A-47CA-B14D-4CD0D1512484Q38290213-9275419E-CA0A-406C-884C-DFC0943638A6Q38312106-7ED3298B-7405-4555-903F-7C5DB426E6A2Q38761355-688563BA-CFA0-4F2D-AFE3-2EF044F15106Q38982288-89D8052A-84AC-4404-AFBB-84C9C2B3A937Q39179774-9AD33A57-40E9-4A90-8FDB-E6C0C084EF88Q39332434-EE031F3E-C63D-4027-97AB-F18DF0FD4972Q52308844-3631E5D6-DFCA-4DFC-83F6-5C5CFE84A200Q54110882-5D7A4635-0F59-4836-BC65-833B8974CD81Q54570250-972DFAA9-804A-4C5E-BE89-46E0A6C12C0AQ56354175-3FFB45C5-71E7-41C3-839A-5AD028C5E5B5Q90905908-B67CE9B0-FC17-4921-AF3E-E822F828D39DQ92258083-0F534AC5-6D09-4ACF-943E-19DEE32A1F19Q92631128-8640DE54-6FCB-42EE-9A3E-464B04C32266
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sophie Groux-Degroote
@de
Sophie Groux-Degroote
@en
Sophie Groux-Degroote
@nl
type
label
Sophie Groux-Degroote
@de
Sophie Groux-Degroote
@en
Sophie Groux-Degroote
@nl
prefLabel
Sophie Groux-Degroote
@de
Sophie Groux-Degroote
@en
Sophie Groux-Degroote
@nl
P106
P21
P31
P496
0000-0002-9964-6519